HC Wainwright Predicts Calumet’s Q1 Earnings (NASDAQ:CLMT)

Calumet, Inc. (NASDAQ:CLMT) – Analysts at HC Wainwright raised their Q1 2026 EPS estimates for Calumet in a note issued to investors on Monday, March 30th. HC Wainwright analyst A. Dayal now anticipates that the oil and gas company will post earnings of ($0.61) per share for the quarter, up from their previous estimate of ($0.63). HC Wainwright currently has a “Buy” rating and a $60.00 target price on the stock. The consensus estimate for Calumet’s current full-year earnings is ($3.02) per share. HC Wainwright also issued estimates for Calumet’s Q2 2026 earnings at ($0.59) EPS, Q3 2026 earnings at ($0.26) EPS, Q4 2026 earnings at ($0.30) EPS, FY2026 earnings at ($1.76) EPS and FY2027 earnings at $1.07 EPS.

Calumet (NASDAQ:CLMT) last issued its earnings results on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.67) by $0.24. The firm had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.04 billion. The business’s revenue was up 9.4% on a year-over-year basis. During the same quarter last year, the business earned ($0.47) EPS.

A number of other equities research analysts also recently commented on CLMT. The Goldman Sachs Group lifted their target price on Calumet from $24.00 to $34.00 and gave the stock a “buy” rating in a report on Thursday, March 12th. UBS Group reiterated a “neutral” rating and issued a $26.00 price target on shares of Calumet in a report on Friday, February 13th. TD Cowen raised their price target on shares of Calumet from $19.00 to $25.00 and gave the stock a “hold” rating in a research report on Thursday, March 5th. Wall Street Zen cut shares of Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a report on Monday, December 29th. Four investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Calumet presently has a consensus rating of “Hold” and an average target price of $30.17.

Calumet Stock Performance

Shares of CLMT stock opened at $34.59 on Wednesday. The stock’s 50-day simple moving average is $27.64 and its 200-day simple moving average is $22.21. The firm has a market capitalization of $3.00 billion, a PE ratio of -88.69 and a beta of 0.85. Calumet has a fifty-two week low of $7.68 and a fifty-two week high of $36.94.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of CLMT. Legal & General Group Plc grew its stake in shares of Calumet by 36.6% during the 2nd quarter. Legal & General Group Plc now owns 72,143 shares of the oil and gas company’s stock worth $1,137,000 after purchasing an additional 19,322 shares during the period. Rhumbline Advisers purchased a new stake in Calumet during the second quarter worth $1,610,000. Ameritas Investment Partners Inc. purchased a new stake in Calumet during the second quarter worth $111,000. XTX Topco Ltd acquired a new stake in Calumet during the second quarter valued at $468,000. Finally, J.W. Cole Advisors Inc. grew its position in Calumet by 32.0% during the second quarter. J.W. Cole Advisors Inc. now owns 23,289 shares of the oil and gas company’s stock valued at $367,000 after buying an additional 5,650 shares during the period. 34.41% of the stock is owned by institutional investors and hedge funds.

Key Stories Impacting Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised Q1–Q4 2026 and FY2026 EPS estimates and boosted FY2027 to $1.07, while keeping a Buy rating and $60 target — this is the core bullish catalyst for the recent rally. Calumet (NASDAQ:CLMT) Stock Price Expected to Rise, HC Wainwright Analyst Says
• Positive Sentiment: Analyst-driven optimism produced a volume‑backed move (Zacks notes a ~12% intraday surge), suggesting momentum and renewed investor interest after the estimate upgrades. Calumet, Inc. (CLMT) Soars 12%: Is Further Upside Left in the Stock?
• Neutral Sentiment: Coverage and commentary are prompting re‑rating conversations; Yahoo Finance looks at valuation after the recent run, which could temper enthusiasm if multiples appear stretched versus fundamentals. A Look At Calumet (CLMT) Valuation After Its Recent Share Price Surge
• Negative Sentiment: Despite upgrades, consensus full‑year estimates remain negative (noted around ($3.02) previously) and the company has a history of volatile quarterly results — fundamentals still need to improve to justify a $60 target, leaving downside risk if momentum fades. MarketBeat CLMT Overview

Calumet Company Profile

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.